Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.55p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.25
  • 52 Week Low: 0.42
  • Currency: UK Pounds
  • Shares Issued: 374.35m
  • Volume: 4,025,787
  • Market Cap: £2.06m
  • RiskGrade: 435

Latest ShareCast News

ValiRx terminates exclusive negotiations with TheoremRx

By Josh White

Date: Thursday 03 Apr 2025

(Sharecast News) - ValiRx announced the immediate termination of its letter of intent with TheoremRx on Thursday, ending exclusive negotiations originally set to run until 31 May.

ValiRx's Inaphaea inks deal with UK-based Screenin3D

By Josh White

Date: Monday 03 Feb 2025

(Sharecast News) - ValiRx announced on Monday that its wholly-owned subsidiary Inaphaea BioLabs has signed an evaluation and commercial use agreement with UK-based Screenin3D.

ValiRx enters evaluation and option deal with Canada's Altus

By Josh White

Date: Wednesday 29 Jan 2025

(Sharecast News) - ValiRx announced on Wednesday that it has entered into an evaluation and option agreement with Canada-based Altus Formulation to assess the potential of Altus' SmartCelle drug delivery technology and novel anti-inflammatory compounds for cancer treatment.

ValiRx further extends letter of intent with The... 31-Dec-2024 ShareCast
ValiRx shares tank on £1.6m fundraising plan to ... 09-Dec-2024 ShareCast
ValiRx subsidiary makes first sale 18-Nov-2024 ShareCast
ValiRx losses narrow in first half 27-Sep-2024 ShareCast
ValiRx pulls out of University of Barcelona coll... 26-Sep-2024 ShareCast
ValiRx subsidiary inks agreement with research f... 18-Sep-2024 ShareCast
ValiRx inks deal with Dundee Drug Discovery Unit 12-Feb-2024 ShareCast
ValiRx enters option deal with Ambrose Healthcare 05-Dec-2023 ShareCast
ValiRx enters partnership with StingRay Bio 10-Nov-2023 ShareCast
ValiRx shares jump as H1 losses shrink 24-Aug-2023 ShareCast
ValiRx subsidiary Inaphaea signs deal with Agili... 14-Aug-2023 ShareCast
ValiRx terminates collaboration with Hokkaido Un... 16-Jun-2023 ShareCast
ValiRx acquires assets of in-liquidation Imagen ... 14-Jun-2023 ShareCast
ValiRx incorporates new wholly-owned lab subsidi... 01-Mar-2023 ShareCast
ValiRx forms new majority-owned breast cancer su... 24-Oct-2022 ShareCast
ValiRx expecting to grant extension of exclusivi... 17-Jun-2022 ShareCast
ValiRx amends longstanding licence deal with Can... 20-Dec-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.55p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.25
52 Week Low 0.42
Volume 4,025,787
Shares Issued 374.35m
Market Cap £2.06m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
19.46% above the market average19.46% above the market average19.46% above the market average19.46% above the market average19.46% above the market average
36.17% above the sector average36.17% above the sector average36.17% above the sector average36.17% above the sector average36.17% above the sector average
Price Trend
97.37% below the market average97.37% below the market average97.37% below the market average97.37% below the market average97.37% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth Not Available

Valirx Dividends

No dividends found

Trades for 23-May-2025

Time Volume / Share Price
15:59 2,355,000 @ 0.55p
14:01 31,000 @ 0.57p
10:24 13,515 @ 0.52p
10:07 6,282 @ 0.52p
09:29 171,500 @ 0.52p

Valirx Key Personnel

CFO Gerald Desler

Top of Page